RedHill Biopharma Ltd. (RDHL)
$0.49-5.77%Close
SELLCRISIS · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $2M
- Beta
- 4.90
- P/E (TTM)
- -3.58
- Short % float
- 9.26%
- Days to cover
- 1.6
- SI change
- -10.2%
- 1W
- +4.26%
- 1M
- -15.52%
- vs SPY 1W
- +4.39%
- vs SPY 1M
- -18.02%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on RDHL?
- LOPJLB’s latest quantitative signal on RedHill Biopharma Ltd. (RDHL) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is RDHL in?
- RedHill Biopharma Ltd. (RDHL) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does RedHill Biopharma Ltd. (RDHL) do?
- RedHill Biopharma Ltd. is a specialized pharmaceutical firm concentrating its efforts mainly on therapies for digestive tract conditions and various infections. The company markets several gastrointestinal medications: Movantik, which addresses opioid-induced constipation in adults experiencing chronic non-cancer pain; Talicia, used to treat Helicobacter pylori infections in adult patients; and…